Search
for
Sort by
Research 121–150 of 1000+
- Insulin sensitiser agents alone and in co-treatment with r-FSH for ovulation induction in PCOS women
- Therapeutic approach for metabolic disorders and infertility in women with PCOS
- Mood disorders and quality of life in polycystic ovary syndrome
- Polycystic Ovary Syndrome and Its Differential Diagnosis
- Thrombin activatable fibrinolysis inhibitor and other hemostatic parameters in patients with polycystic ovary syndrome
- Observation of phenotypic variation among Indian women with polycystic ovary syndrome (PCOS) from Delhi and Srinagar
- Age-related differences in the reproductive and metabolic implications of polycystic ovarian syndrome: findings in an obese, United States population
- Cardiac flow parameters with conventional and pulsed tissue Doppler echocardiography imaging in patients with polycystic ovary syndrome
- Treatment of androgen excess in females: Yesterday, today and tomorrow
- Treatment of hyperandrogenism in women
- Sertoli–Leydig cell tumors: hormonal profile after dynamic test with GnRH analogue: triptorelin represents a useful tool to evaluate tumoral hyperandrogenism
- A rare case of an androgen-producing stromal luteoma of the ovary in a postmenopausal woman, diagnosed by means of selective venous blood sampling
- Stromal Cells of the Human Postmenopausal Ovary Display a Distinctive Biochemical and Molecular Phenotype
- Postmenopausal Ovarian Hyperthecosis Associated with Rapid Testosterone Excess
- The Optimal Number of Ovarian Punctures to Be Applied During Laparoscopic Ovarian Diathermy in Women with Polycystic Ovarian Syndrome
- Treatment of female sexual dysfunction in postmenopausal women—What is the evidence?
- What is your diagnosis?
- Ovarian steroid cell tumor (not otherwise specified) with subsequent spontaneous pregnancy after tumor removal: a case report and literature review
- miR-761-hepcidin/Gpx4 pathway contribute to unexplained liver dysfunction in polycystic ovary syndrome by regulating liver iron overload and ferroptosis
- Comparison of resumption of ovulation after cessation of oral contraceptives and medroxyprogesterone acetate in women with polycystic ovary syndrome
- Polycystic ovary syndrome: pragmatic management across levels of care
- Association of severity of menstrual dysfunction with cardiometabolic risk markers among women with polycystic ovary syndrome
- The investigation and management of the hirsute woman
- The impact of physical activity in a case of polycystic ovary syndrome
- The Evaluation and Management of Hirsutism
- The safety of 52 weeks of oral DHEA therapy for postmenopausal women
- Testosterone therapy in women: Myths and misconceptions
- Androgen treatment of postmenopausal women
- Testosterone implants in women: Pharmacological dosing for a physiologic effect
- Expression of 11β-hydroxysteroid dehydrogenase type 1 in visceral and subcutaneous adipose tissues of patients with polycystic ovary syndrome is associated with adiposity